Skip to main navigation Skip to search Skip to main content

Transfection of ovarian cancer cells with tumor necrosis factor-α (TNF-α) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-α

  • S. Wu
  • , W. A. Merkur
  • , J. R. Wiener
  • , A. Berchuck
  • , R. C. Bast
  • , C. M. Boyer

Research output: Contribution to journalArticlepeer-review

Abstract

Recombinant interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) can induce endogenous TNF-α mRNA expression and stimulate proliferation of epithelial ovarian cancer cells. In a previous report, proliferation induced by either cytokine could be partially blocked by soluble TNF-α receptor or by neutralizing antibodies against TNF-α. In the present study, we have transfected the ovarian cancer cell line OVCA 432 with vectors that contain the TNF-α gene in the antisense or sense orientation. Antisense-transfected cells showed a 4.5- to 26-fold reduction in IL-1-induced TNF-α secretion. Similarly, the stimulation of [3H]thymidine incorporation by IL-1 but not by TNF-α was blocked by TNF-α antisense transfection. These results are consistent with a model in which the macrophage-derived cytokines IL-1 and TNF-α might stimulate endogenous production of TNF-α that in turn could stimulate proliferation of ovarian cancer cells by autocrine growth regulation.

Original languageEnglish (US)
Pages (from-to)59-63
Number of pages5
JournalGynecologic oncology
Volume53
Issue number1
DOIs
StatePublished - Apr 1994
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Transfection of ovarian cancer cells with tumor necrosis factor-α (TNF-α) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-α'. Together they form a unique fingerprint.

Cite this